1 – 10 of 29
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Results of the first nationwide cohort study of outcomes in dialysis and kidney transplant patients before and after vaccination for COVID-19
(
- Contribution to journal › Article
-
Mark
Treatment and long-term outcome in primary nephrogenic diabetes insipidus
(
- Contribution to journal › Article
- 2022
-
Mark
The management of membranous nephropathy—an update
(
- Contribution to journal › Article
-
Mark
Perspective on COVID-19 vaccination in patients with immune-mediated kidney diseases : consensus statements from the ERA-IWG and EUVAS
(
- Contribution to journal › Scientific review
- 2021
-
Mark
COVID-19 and ANCA-associated vasculitis : Recommendations for vaccine preparedness and the use of rituximab
(
- Contribution to journal › Letter
- 2020
-
Mark
Recommendations for the management of patients with immune-mediated kidney disease during the severe acute respiratory syndrome coronavirus 2 pandemic
(
- Contribution to journal › Article
- 2018
-
Mark
High doses of cholecalciferol alleviate the progression of hyperparathyroidism in patients with CKD Stages 3-4 : Results of a 12-week double-blind, randomized, controlled study
(
- Contribution to journal › Article
-
Mark
Comparison of glomerular filtration rate estimating equations derived from creatinine and cystatin C : Validation in the Age, Gene/Environment Susceptibility-Reykjavik elderly cohort
(
- Contribution to journal › Article
-
Mark
Long-term renal outcome in children with OCRL mutations : Retrospective analysis of a large international cohort
(
- Contribution to journal › Article
- 2017
-
Mark
Clinical Practice Guideline on management of older patients with chronic kidney disease stage 3b or higher (EGFR<45 mL/min/1.73 m2) : A summary document from the European Renal Best Practice Group
(
- Contribution to journal › Scientific review